Drug Type Virus-like particle vaccine, Prophylactic vaccine |
Synonyms H5N1 VirusLike Particle (VLP) Influenza vaccine (recombinant) Novavax, H5N1 viruslike particle pandemic influenza vaccine Novavax |
Target- |
Action stimulants |
Mechanism Immunostimulants |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Influenza A virus infection | Phase 1 | United States | - |